TAIWO SOWUNMI: Open Payments
NPI 1013626829 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 23 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $669
Food & beverage: $661Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $273 |
| Janssen Pharmaceuticals, Inc | 7 | $224 |
| ABBVIE INC. | 2 | $101 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: SPRAVATO, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, Qelbree, CAPLYTA, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
